Main functions
- "1.Relieves Neuropathic Pain: ARA-290 exerts analgesic effects through two pathways: downregulating inflammation via IRR targeting and directly inhibiting TRPV1 channel activity (a key pain receptor), thereby reducing capsaicin-induced mechanical hyperalgesia. In a clinical study of sarcoidosis-associated small nerve fiber loss, ARA-290 significantly improved SFNSL (Small Fiber Neuropathy Symptoms List) scores.
- 2.Neuroprotection and Cerebral Ischemia Protection: In a mouse model of middle cerebral artery occlusion (MCAO), ARA-290 significantly reduced infarct volume, neuronal apoptosis, and inflammatory cytokine levels (TNF-α, IL-1β, IL-6), demonstrating neuroprotective effects comparable to EPO without causing splenomegaly or erythropoiesis. These effects are mediated through the β-common receptor (βCR).
- 3.Cardioprotection and Delaying Age-Related Cardiac Decline: In a 15-month randomized controlled trial in aged rats, ARA-290 reduced the cardiac non-myocyte/myocyte ratio, infiltrating leukocytes and monocytes, and pro-inflammatory cytokines, while preserving left ventricular ejection fraction and significantly improving frailty index and healthspan.
- 4.Anti-Inflammatory and Immunomodulatory Effects: In chronic stress-induced depression mouse models, ARA-290 reduced CD11b⁺Ly6G⁺ neutrophils and CD11b⁺Ly6C⁺ monocytes in bone marrow and meninges, and reversed microglial activation, thereby ameliorating depression-like behavior. It also showed potential in reducing immune cell activity in a colitis mouse model.
- 5.Metabolic Regulation: A Phase II clinical trial is investigating ARA-290's effects on glucose tolerance, insulin secretion, and insulin sensitivity in prediabetic and drug-naïve type 2 diabetes patients (NCT01933529).
- 6.Potential for Early Ischemic Tissue Diagnosis: Due to its specific binding to hypoxic tissues, researchers have developed radiolabeled ⁹⁹ᵐTc-DOTA-ARA-290 for SPECT cardiac ischemia imaging, achieving an ischemic-to-lung uptake ratio of 3.65 in animal models, suggesting potential for early myocardial ischemia diagnosis."